HARRELL INVESTMENT PARTNERS, LLC

Position in NVO — Novo Nordisk A S

CIK 1802882 AUSTIN, TX

Position in NVO

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$769,053

+$220,633 QoQ

Shares Held

16,042

+7.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#582

of 1,348 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HARRELL INVESTMENT PARTNERS, LLC holds $21,101,607 across 6 Drug Manufacturers - General names. NVO ranks #4 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	40,541	$10,296,197
2	ABBV	AbbVie Inc.	31,506	$7,928,169
3	NVS	Novartis AG	6,498	$1,018,366
4	NVO	Novo Nordisk A S This page	16,042	$769,053
5	LLY	ELI LILLY & Co	584	$700,467
6	MRK	Merck & Co., Inc.	3,030	$389,355

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$769,053	16,042	+7.5%	Shares	Sole	2026-07-09
2026-03-31	$548,420	14,923	+15.9%	Shares	Sole	2026-04-22
2025-12-31	$655,130	12,876	-9.1%	Shares	Sole	2026-01-15
2025-09-30	$786,126	14,167	+5.8%	Shares	Sole	2025-10-23
2025-06-30	$924,315	13,392	—	Shares	Sole	2025-07-15
No filing history on record for this holder in this stock.